Adrenal medulla in neural grafting and neural plasticity.
The recent history of neural transplantation using the adrenal medulla parallels an evolution in our thinking about neural grafting as a therapeutic approach to treat neurodegenerative diseases such as Parkinson's disease. Initially, neural grafting was an approach to study development and regeneration. With the discovery that adrenal chromaffin cell grafts would ameliorate some of the motor deficits associated with the loss of striatal dopamine, adrenal grafts were used to provide dopamine to the dopamine-depleted striatum. However, subsequent studies showed poor chromaffin cell survival unless trophic factors were present at the site of transplantation. These experiments lead to the appreciation of the complex interactions between neurotrophic factors, inflammatory cytokines, the grafted tissue, and the host brain's response. Thus, we find ourselves again using neural transplantation as an approach to help us better understand central nervous system plasticity and the features this plasticity shares in common with development and regeneration.
Hansen
J T
JT
Department of Neurobiology and Anatomy, University of Rochester School of Medicine and Dentistry, New York 14642.
Gash
D M
DM
D000313:Adrenal Medulla / Q000196:embryology / Q000637:transplantation*; D000818:Animals; D016380:Brain Tissue Transplantation; D002838:Chromaffin System / Q000502:physiology; D003342:Corpus Striatum / Q000473:pathology; D016332:Fetal Tissue Transplantation; D006085:Graft Survival; D006801:Humans; D009473:Neuronal Plasticity / Q000502:physiology*; D010300:Parkinson Disease / Q000503:physiopathology / Q000601:surgery